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Background: Mitochondrial diseases (MDs) (1:5000-10000) represents a wide group of human 
disorders associated with mitochondrial DNA (mtDNA) variations causing defect of oxidative 
phosphorylation system, whereas nuclear genome mutations are somewhat rare. The extremely 
heterogeneous clinical phenotype, extending from oligosymptomatic condition to complex 
syndromes involving neurological, ophtalmological, gastroenterological and endocrine features, 
depends to the involved tissue well as to the specific mtDNA mutations and their heteroplasmic 
level. Diabetes and deafness are common features of mitochondrial diseases, while renal alterations 
are rarely reported, especially in adults, probably because of  lack of association to mitochondrial 
conventional phenotypes.   
Case Presentation: We investigated a 62 years old male affected by hypertrophic cardiomyopathy 
(HCM) and renal failure that caused already a bilateral transplantation. Pathological anamnesis 
revealed also diabetes, deafness and Crohn disease. Family history of cardiomyopathy  showed a 
strong mitochondrial involvement. The proband's mother,  three brothers (one of which died of renal 
failure at 26 years), the sister and her child were affected. 
Materials and Methods: Genomic DNA from peripheral blood and buccal cells was extracted with 
the Kit-Nucleon-BACC2 (Illustra DNA-Extraction Kit-BACC2-GE Healthcare, UK) and the whole 
mitochondrial genome was amplified by two pair of primers designed in our laboratory to generate 
two overlapping fragments. The PCR products were then sequenced and compared to mitochondrial 
reference sequence (rCRS NC_012920).  
Results and Discussion: In both biological samples the mtDNA analysis showed the heteroplasmic 
A3243G mutation in the tRNALeu (UUR), frequently associated with MDs.  
A cardiological involvement leading to hypertrophic remodelling, caused to mitochondria 
intermyofibrillar proliferation, occurs up to 40% of patients with mtDNA disease. Molecular 
backgrounds of mitochondrial cardiomyopathy of adult age are still quite poorly known and the 
A3243G mutation in tRNA Leu(UUR) of mtDNA has been reported in 40-60% of patients with HCM. 
The interesting finding presented here support the knowledge that mitochondrial gene altertation 
represents a possible etiology in cardiological patients with unexplained renal failure. This is 
particularly true, as in this case, when other associated symtoms linked with dysfunctional oxidative 
phosphorylation are present. 
The case presented in this report further suggests that a differential diagnosis in presence of HCM 
should be solved by a multidisciplinary approach together with mutation analysis of mitochondrial 
DNA. 
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